Hyperplasia Stocks List

Recent Signals

Date Stock Signal Type
2021-02-24 BBIO Pocket Pivot Bullish Swing Setup
2021-02-24 BBIO 50 DMA Support Bullish
2021-02-24 BSX Stochastic Reached Overbought Strength
2021-02-24 BSX MACD Bullish Signal Line Cross Bullish
2021-02-24 BSX Cup with Handle Other
2021-02-24 LLY Crossed Above 20 DMA Bullish
2021-02-24 MLND 20 DMA Resistance Bearish
2021-02-24 NYMX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-24 NYMX MACD Bearish Signal Line Cross Bearish
2021-02-24 NYMX 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-24 SPRB Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-02-24 SPRB 50 DMA Resistance Bearish
2021-02-24 SPRB MACD Bullish Signal Line Cross Bullish
2021-02-24 SPRB Crossed Above 20 DMA Bullish
2021-02-24 VERU Narrow Range Bar Range Contraction
2021-02-24 VERU NR7 Range Contraction

Recent News for Hyperplasia Stocks

Date Stock Title
Feb 24 LLY Lilly to Participate in Cowen Health Care Conference
Feb 24 LLY Top 15 Pharmaceutical Companies With Highest R&D Spending
Feb 23 LLY Big Pharma Short Percentage Is Below Overall Market
Feb 23 BSX This Medical Stock Just Retook Its Buy Point On Its Unexpected Earnings Beat
Feb 23 VERU Veru Files US Application For TADFIN Combo For Prostate Enlargement
Feb 23 LLY Veru Files US Application For TADFIN Combo For Prostate Enlargement
Feb 23 VERU Veru submits TADFIN new drug application for benign prostatic hyperplasia
Feb 23 BSX This Medical Stock Just Retook Its Buy Point On Unexpected Earnings Beat
Feb 23 VERU Veru Submits New Drug Application for Proprietary TADFIN for BPH
Feb 23 LLY Eli Lilly Is Poised for a Pullback Before Renewed Longer-Term Gains
Feb 21 LLY 3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring
Feb 20 BBIO The Past Week's Notable Insider Buys: More Biotech IPOs, Bumble, Fiserv And More
Feb 19 LLY Avidity Biosciences shares soar 18% in afternoon trading
Feb 19 BBIO BridgeBio Pharma's BBP-418 Muscular Dystrophy Study Moves Forward With Patient Dosing
Feb 19 BBIO BridgeBio Pharma initiates dosing in mid-stage muscular dystrophy trial
Feb 19 BBIO BridgeBio Pharma and Affiliate ML Bio Solutions Announce Dosing of First Patient in Phase 2 Trial of BBP-418 in Limb Girdle Muscular Dystrophy Type 2i (LGMD2i)
Feb 19 LLY The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
Feb 18 LLY Why Rigel Pharmaceuticals Stock Is Jumping Today
Feb 18 LLY Lilly Strikes Licensing Deal With Rigel In Push Toward Neurological, Immunological Therapies
Feb 18 LLY The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout

Hyperplasia (from ancient Greek ὑπέρ huper, "over" + πλάσις plasis, "formation"), or hypergenesis, is an increase in the amount of organic tissue that results from cell proliferation. It may lead to the gross enlargement of an organ, and the term is sometimes confused with benign neoplasia or benign tumor.Hyperplasia is a common preneoplastic response to stimulus. Microscopically, cells resemble normal cells but are increased in numbers. Sometimes cells may also be increased in size (hypertrophy). Hyperplasia is different from hypertrophy in that the adaptive cell change in hypertrophy is an increase in the size of cells, whereas hyperplasia involves an increase in the number of cells.

More about Hyperplasia
Browse All Tags